公开(公告)号：US20210403420A1

公开(公告)日：2021-12-30

申请号：US16641971

申请日：2019-08-26

Applicant: SCOHIA PHARMA, INC.

Inventor： Ryoma HARA ,  Kohei ASANO ,  Ayumu NIIDA ,  Shizuo KASAI ,  Tsuyoshi MAEKAWA

IPC: C07C279/18 ,  A61K9/00 ,  A61P3/04

Abstract: The present invention provides a benzoic acid ester compound that has an enteropeptidase inhibitory effect, and use of the compound as a medicament for the treatment or prevention of obesity, diabetes mellitus, or the like.
A compound represented by the formula (I) or a salt thereof has an enteropeptidase inhibitory effect and is useful as a medicament for the treatment or prevention of obesity, diabetes mellitus, or the like: [in the formula, each symbol is as defined in the specification].